Cite Filings / TSHA / 0001415889-25-022685

Feed Companies Filings Check

Sign in

144

Sale of Securities

Taysha Gene Therapies, Inc. Filed 2025-08-21 Acc 0001415889-25-022685

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-08-22 4 President and Head of R&D sold 57,054 shares at $2.85 ($162,604)
2025-08-22 4 CHIEF FINANCIAL OFFICER sold 54,491 shares at $2.85 ($155,299)
2025-08-21 144 Sale of Securities
2025-08-21 144 Sale of Securities
2025-08-21 144 Sale of Securities
2025-08-21 144 Sale of Securities
2025-08-21 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…